RGNX REGENXBIO Inc.

NASDAQ
$7.40

REGENXBIO Inc. (RGNX) Insider Activity

What the officers, directors and large holders did with their own shares. Only open-market purchases and sales count toward the totals — grants, option exercises and shares withheld for tax are compensation mechanics, not decisions, and they're listed separately below.

30D 90D 6M 1Y
Insider signal In line Selling ran in line with RGNX's own trailing one-year pace, with 46% of sale value under a prearranged plan.
Cluster activity 1 buyer in the last 30 days 1 buyer in the last 90 days 1 seller in the last 90 days
Insiders buying
1
2 transactions
Insiders selling
2
7 transactions
Purchases
$949.4K
102,603 shares
Sales
$1.3M
107,362 shares
Net activity
-$329.7K
purchases less sales

How much of that selling was preplanned? 46% planned / 54% discretionary

10b5-1 plan sales $590.3K 5 transactions · 51,029 shares
Discretionary sales $688.8K 2 transactions · 56,333 shares

Largest single sale: $472.3K.

Where they traded

Buy Sell Dot area is proportional to transaction value.

Last open-market purchase: August 27, 2026 , by Ciongoli Gregory Austin .

Recent open-market activity

Date Insider Role Action Shares Price Value Held after
Ciongoli Gregory Austin Director Buy 53,407 $9.36 $499.7K 118,035
Ciongoli Gregory Austin Director Buy 49,196 $9.14 $449.7K 64,628
PAKOLA STEVE Chief Medical Officer Sell 10b5-1 2,161 $13.64 $29.5K 213,009 −1% of holding
PAKOLA STEVE Chief Medical Officer Sell 36,725 $12.86 $472.3K 213,009 −14.7% of holding
PAKOLA STEVE Chief Medical Officer Sell 19,608 $11.04 $216.5K 213,009 −8.4% of holding
PAKOLA STEVE Chief Medical Officer Sell 10b5-1 15,309 $11.02 $168.7K 232,617 −6.2% of holding
PAKOLA STEVE Chief Medical Officer Sell 10b5-1 5,124 $10.35 $53.0K 247,926 −2% of holding
Simpson Curran Chief Executive Officer Sell 10b5-1 20,811 $12.62 $262.6K 216,162 −8.8% of holding
Simpson Curran Chief Executive Officer Sell 10b5-1 7,624 $10.03 $76.5K 236,973 −3.1% of holding

Form 4s are due within two business days of a transaction, so this is close to real time — unlike the quarterly 13F data on the Institutional tab. A single large sale often reflects a prearranged 10b5-1 plan rather than a fresh view, so read a pattern of sales rather than any one of them.